IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 59 filers reported holding IKENA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,315,065 | -31.8% | 534,657 | +3.3% | 0.01% | -26.3% |
Q2 2023 | $3,395,213 | +86.0% | 517,563 | -2.2% | 0.02% | +58.3% |
Q1 2023 | $1,825,050 | +29.7% | 529,000 | 0.0% | 0.01% | +71.4% |
Q4 2022 | $1,407,140 | -25.1% | 529,000 | 0.0% | 0.01% | -36.4% |
Q3 2022 | $1,878,000 | -19.8% | 529,000 | 0.0% | 0.01% | -69.4% |
Q2 2022 | $2,343,000 | – | 529,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,249,123 | $9,738,703 | 8.94% |
CHI Advisors LLC | 2,180,934 | $9,443,445 | 3.74% |
Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21,728,711 | 3.36% |
ACUTA CAPITAL PARTNERS, LLC | 551,010 | $2,385,873 | 1.60% |
Vida Ventures Advisors, LLC | 225,192 | $975,081 | 1.51% |
BVF INC/IL | 3,169,164 | $13,722,480 | 0.37% |
Artal Group S.A. | 1,849,513 | $8,008 | 0.34% |
Orbimed Advisors | 3,186,166 | $13,796,099 | 0.29% |
OUP Management Co., LLC | 26,833 | $116,187 | 0.26% |
Avoro Capital Advisors LLC | 1,640,000 | $7,101,200 | 0.11% |